Rosenblum Mark J 4/A
4/A · Salarius Pharmaceuticals, Inc. · Filed Nov 8, 2022
Insider Transaction Report
Form 4/AAmended
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Common Stock
2022-11-03$1.73/sh+7,314$12,682→ 13,245 total
Footnotes (1)
- [F1]These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c)